These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 15495575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [Abstract] [Full Text] [Related]

  • 4. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends.
    Huong NT, Lan NT, Cobelens FG, Duong BD, Co NV, Bosman MC, Kim SJ, van Soolingen D, Borgdorff MW.
    J Infect Dis; 2006 Nov 01; 194(9):1226-32. PubMed ID: 17041848
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
    Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P, Nunn P.
    N Engl J Med; 1998 Jun 04; 338(23):1641-9. PubMed ID: 9614254
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.
    Arch Inst Pasteur Madagascar; 2002 Jun 04; 68(1-2):44-7. PubMed ID: 12643091
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW, Abate G, Lakew M, Goshu S, Aseffa A.
    Ethiop Med J; 2008 Jul 04; 46(3):219-25. PubMed ID: 19271385
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T, Yanai H, Rhiengtong D, Palittapongarnpim P, Nampaisan O, Supawitkul S, Uthaivorawit W, Mori T.
    Int J Tuberc Lung Dis; 2004 Jan 04; 8(1):31-8. PubMed ID: 14974743
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
    Abate G.
    Ethiop Med J; 2002 Jan 04; 40(1):79-86. PubMed ID: 12240570
    [Abstract] [Full Text] [Related]

  • 18. [Surveillance of antituberculosis-drug resistance in Cuba, 2010-2011].
    Lemus D, Echemendía M, Díaz R, Llop A, Llanes MJ.
    Biomedica; 2014 Apr 04; 34 Suppl 1():108-13. PubMed ID: 24968042
    [Abstract] [Full Text] [Related]

  • 19. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2004 Jun 04; 8(6):760-6. PubMed ID: 15182147
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.